BioGaia publishes annual report for 2018

Today, BioGaia AB (publ) publishes the Annual Report for the financial year 2018. The report is held available at BioGaia’s website biogaia.com under the section "Investors – Financial reports". Shareholders and other stakeholders wishing to have the annual report sent to them may request so by email to info@biogaia.se.

This is information that BioGaia AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 1 pm CET on 25 March 2019.

Latest press releases from BioGaia
2019-03-18 Finland first market to launch BioGaia Protectis capsules
2019-02-07 Year-end report 2018
2018-11-26 Sale of shares in BioGaia AB

For additional information please contact
Isabelle Ducellier, Managing Director, telephone: +46 8 555 293 00

BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com

Tags:

About Us

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com If you need more information about BioGaia and our products please visit our website or download our press kit from: http://www.biogaia.com/press-material